Company: BACC
Filing Date: 2025-03-26
Form Type: DRS
Source: 0001185185-25-000217
Chunk: 4

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-03-26
Form: DRS
Chunk 4
---
the underwriters’ over-allotment option is exercised in full) and BTIG and Roberts & Ryan have agreed to purchase 150,000 private
placement units (or 195,000 private placement units if the underwriters’ over-allotment option is exercised in full). The private
placement units are identical to the units sold in this offering, subject to certain limited exceptions as described in this prospectus.
[*] institutional investors (none of which are affiliated with any member of our management, our sponsor, BTIG, Roberts & Ryan or
any other investor), which we refer to as the “non- managing sponsor investors” throughout this prospectus, have expressed
an interest to indirectly purchase, through purchase of non-managing sponsor membership interests, an aggregate of 365,000 private placement
units (or 376,250 private placement units if the underwriters’ over-allotment option is exercised in full) at a price of $10.00
per unit ($3,650,000 in the aggregate, or $3,762,500 if the underwriters’ over-allotment option is exercised in full) in a private
placement that will close simultaneously with the closing of this offering. Subject to each non-managing sponsor investor purchasing,
through the sponsor, the private placement units allocated to it in connection with the closing of this offering, the sponsor will issue
membership interests at a nominal purchase price of $0.004 per underlying founder share to the non-managing sponsor investors reflecting
indirect interests in an aggregate of 3,271,739 founder shares (or 3,762,500 founder shares if the underwriters exercise the over-allotment
option in full) held by the sponsor.

The non-managing sponsor investors have expressed
to us an interest in purchasing an aggregate of approximately $[*] million of the public units in this offering at the offering
price (assuming the exercise in full of the underwriters’ over-allotment option), or approximately [*]%, of the public units at
the offering price. None of the non-managing sponsor investors has expressed to us an interest in purchasing more than 9.9% of the units
to be sold in this offering. There can be no assurance that the non-managing sponsor investors will acquire any units, either directly
or indirectly, in this offering, or as to the amount of the units the non-managing sponsor investors will retain, if any, prior to or
upon the consummation of our initial